GARRE1

Across TCGA pan-cancer cohorts, GARRE1 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of GARRE1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where GARRE1 RNA is repressed in tumor relative to normal tissue. In most cancer types GARRE1 is over-expressed in tumor, although a few such as KICH and LUSC show the opposite, repressed pattern.

KICH, LUSC, and LIHC are the cancer types where GARRE1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GARRE1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	Female	All	−1.081	<.001	8	view →
LUSC	Female	II,III,IV	−1.108	<.001	6	view →
LIHC	Female	II,III,IV	+0.910	<.001	6	view →
LUAD	Female	II,III,IV	−0.831	<.001	6	view →
BRCA	All	III,IV	−0.531	<.001	6	view →
UCEC	All	All	−0.837	<.001	4	view →
HNSC	Female	III,IV	+0.701	.004	4	view →
CHOL	All	All	+1.274	<.001	3	view →
THCA	All	II,III,IV	−0.383	.014	3	view →
COAD	All	All	+0.273	.007	3	view →
KIRP	Male	All	−0.431	.005	2	view →
KIRC	All	All	+0.227	.022	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

GARRE1–KICH

Open the KICH breakdown →